Literature DB >> 22434703

Breast hemangiomas: correlation between imaging and pathologic findings.

Amara Tilve1, Rosa Mallo, Alberto Pérez, Paz Santiago.   

Abstract

Hemangiomas are benign vascular tumors that are rare in the breast. A high percentage of hemangiomas are diagnosed incidentally during imaging examinations. They have mammographic, sonographic, and pathologic characteristics that allow radiologists and pathologists to diagnose them. We present four different cases of breast hemangiomas showing their mammographic and sonographic features. Two were diagnosed with an 18-gauge core needle biopsy and they underwent surgical excision. The other two cases were diagnosed with a 14-gauge core needle biopsy and their radiologic and pathologic appearances were concordant with breast hemangiomas, so they did not need surgical excision and are being followed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22434703     DOI: 10.1002/jcu.21904

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  4 in total

1.  Sinusoidal hemangioma of the breast: diagnostic evaluation management and literature review.

Authors:  Nikolaos S Salemis
Journal:  Gland Surg       Date:  2017-02

Review 2.  Contrast-enhanced ultrasound features of breast capillary hemangioma: a case report and review of literature.

Authors:  Chen-Pin Chou; Jer-Shyung Huang; Jyh-Seng Wang; Huay-Ben Pan
Journal:  J Ultrasound       Date:  2021-01-06

3.  A suspicious breast lesion detected by dynamic contrast-enhanced MRI and pathologically confirmed as capillary hemangioma: a case report and literature review.

Authors:  Lian-He Yang; Shuang Ma; Qing-Chang Li; Hong-Tao Xu; Xin Wang; En-Hua Wang
Journal:  Korean J Radiol       Date:  2013-11-05       Impact factor: 3.500

4.  Breast hemangioma with difficulty in preoperative diagnosis: a case report.

Authors:  Naotake Funamizu; Isao Tabei; Chikako Sekine; Azusa Fuke; Mitsuo Yabe; Hiroshi Takeyama; Tomoyoshi Okamoto
Journal:  World J Surg Oncol       Date:  2014-10-14       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.